160 related articles for article (PubMed ID: 32540257)
1. A tearfully painful darkness.
Leishangthem L; Beres S; Moss HE; Chen J
Surv Ophthalmol; 2021; 66(3):543-549. PubMed ID: 32540257
[TBL] [Abstract][Full Text] [Related]
2. Resolution of myelin oligodendrocyte glycoprotein (MOG)-IgG optic neuritis without treatment.
Vosoughi AR; Micieli JA
Mult Scler Relat Disord; 2020 Nov; 46():102456. PubMed ID: 32853896
[TBL] [Abstract][Full Text] [Related]
3. Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in a post-COVID-19 infection patient.
Zaini MA; Mohd Zain A; Md Din N; Lam C
Immun Inflamm Dis; 2023 Oct; 11(10):e1051. PubMed ID: 37904693
[TBL] [Abstract][Full Text] [Related]
4. Myelin oligodendrocyte glycoprotein (MOG) associated optic neuritis in a patient with idiopathic intracranial hypertension (IIH) and compressive optic neuropathy case report.
Sorensen RD; Vogt A; Laylani N; Pakravan M; Lee AG
BMC Ophthalmol; 2024 Feb; 24(1):61. PubMed ID: 38350984
[TBL] [Abstract][Full Text] [Related]
5. First Clinical Experience with Anti-myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis.
Heckmann J; Todorova M; Müller S; Broser PJ; Sturm V
Klin Monbl Augenheilkd; 2020 Apr; 237(4):458-463. PubMed ID: 32092775
[TBL] [Abstract][Full Text] [Related]
6. Myelin Oligodendrocyte Glycoprotein Optic Neuritis Presenting With Orbital Apex Syndrome.
Sulaiman FN; Kamardin NF; Sultan Abdul Kader MI; Ch'ng H; Wan Abdul Halim WH
Cureus; 2023 May; 15(5):e38975. PubMed ID: 37313108
[TBL] [Abstract][Full Text] [Related]
7. Optic perineuritis with anti-myelin oligodendrocyte glycoprotein antibody.
Yanagidaira M; Hattori T; Emoto H; Kiyosawa M; Yokota T
Mult Scler Relat Disord; 2020 Feb; 38():101444. PubMed ID: 31711001
[TBL] [Abstract][Full Text] [Related]
8. Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome.
Chen JJ; Flanagan EP; Jitprapaikulsan J; López-Chiriboga ASS; Fryer JP; Leavitt JA; Weinshenker BG; McKeon A; Tillema JM; Lennon VA; Tobin WO; Keegan BM; Lucchinetti CF; Kantarci OH; McClelland CM; Lee MS; Bennett JL; Pelak VS; Chen Y; VanStavern G; Adesina OO; Eggenberger ER; Acierno MD; Wingerchuk DM; Brazis PW; Sagen J; Pittock SJ
Am J Ophthalmol; 2018 Nov; 195():8-15. PubMed ID: 30055153
[TBL] [Abstract][Full Text] [Related]
9. Atypical Case of MOG Antibody-Associated Optic Neuritis with Roth Spots.
Aboab J; Errera MH; Espinoza S; Girmens JF; Héron E
Ocul Immunol Inflamm; 2023 Jul; 31(5):1068-1072. PubMed ID: 35522251
[TBL] [Abstract][Full Text] [Related]
10. [A case of recurrent optic neuritis associated with cerebral and spinal cord lesions and autoantibodies against myelin oligodendrocyte glycoprotein relapsed after fingolimod therapy].
Miyazaki T; Nakajima H; Motomura M; Tanaka K; Maeda Y; Shiraishi H; Tsujino A
Rinsho Shinkeigaku; 2016 Apr; 56(4):265-9. PubMed ID: 27010093
[TBL] [Abstract][Full Text] [Related]
11. Myelin Oligodendrocyte Glycoprotein-IgG-positive Recurrent Bilateral Optic Papillitis with Serous Retinal Detachment.
Kon T; Hikichi H; Ueno T; Suzuki C; Nunomura J; Kaneko K; Takahashi T; Nakashima I; Tomiyama M
Intern Med; 2018 Nov; 57(22):3307-3312. PubMed ID: 29780155
[TBL] [Abstract][Full Text] [Related]
12. Postinfectious Anti-Myelin Oligodendrocyte Glycoprotein Antibody Positive Optic Neuritis and Myelitis.
Vieira JP; Sequeira J; Brito MJ
J Child Neurol; 2017 Oct; 32(12):996-999. PubMed ID: 28820014
[TBL] [Abstract][Full Text] [Related]
13. Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis.
Chen JJ; Bhatti MT
Curr Opin Neurol; 2020 Feb; 33(1):47-54. PubMed ID: 31743235
[TBL] [Abstract][Full Text] [Related]
14. Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in a COVID-19 patient: A case report.
Kogure C; Kikushima W; Fukuda Y; Hasebe Y; Takahashi T; Shibuya T; Sakurada Y; Kashiwagi K
Medicine (Baltimore); 2021 May; 100(19):e25865. PubMed ID: 34106635
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial.
Chen JJ; Tobin WO; Majed M; Jitprapaikulsan J; Fryer JP; Leavitt JA; Flanagan EP; McKeon A; Pittock SJ
JAMA Ophthalmol; 2018 Apr; 136(4):419-422. PubMed ID: 29470571
[TBL] [Abstract][Full Text] [Related]
16. Myelin oligodendrocyte glycoprotein antibody-associated bilateral optic neuritis with unilateral prepapillary vitreous hemorrhage.
Mudri J; Warne R; Lock J; Shah S
J AAPOS; 2022 Jun; 26(3):161-164. PubMed ID: 35525384
[TBL] [Abstract][Full Text] [Related]
17. Clinical presentation of optic neuritis with autoantibodies anti-myelin oligodendrocyte glycoprotein.
Ducloyer JB; Michel L; Wiertlewski S; Lebranchu P
Eur J Ophthalmol; 2019 Mar; 29(2):257-261. PubMed ID: 29972029
[TBL] [Abstract][Full Text] [Related]
18. Shot in the dark.
Bhatti MT; Gilbert AL; Watson G; Waheed M; Spencer D
Surv Ophthalmol; 2023; 68(4):821-829. PubMed ID: 36150481
[TBL] [Abstract][Full Text] [Related]
19. A case of MOG antibody-positive bilateral optic neuritis and meningoganglionitis following a genital herpes simplex virus infection.
Nakamura M; Iwasaki Y; Takahashi T; Kaneko K; Nakashima I; Kunieda T; Kaneko S; Kusaka H
Mult Scler Relat Disord; 2017 Oct; 17():148-150. PubMed ID: 29055448
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and prognosis of myelin oligodendrocyte glycoprotein antibody-seropositive paediatric optic neuritis in China.
Song H; Zhou H; Yang M; Tan S; Wang J; Xu Q; Liu H; Wei S
Br J Ophthalmol; 2019 Jun; 103(6):831-836. PubMed ID: 30049802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
